Salmonella Risk Prompts Standard Process Supplement Recall
July 3, 2012
PALMYRA, Wis.Standard Process Inc. voluntarily recalled three supplements due to potential salmonella contamination. The recall resulted during an FDA inspection, which revealed one of the ingredients used in these products potentially contained salmonella.
Ann Holden, vice president of quality control, Standard Process, said she could not say where in the manufacturing process the possible contamination occurred due to proprietary information, but she said, "Standard Process has taken immediate steps to address the specific situation." Standard Process, which has a microbiological laboratory on its premises, tested retained samples of these products for salmonella. In all instances, salmonella has been tested for and confirmed absent, according to FDA.
The products were sold to consumers through health care professionals, and the company has ceased distribution of the product lots in question.
Holden added, "We apologize for any inconvenience that the voluntary recall may have caused."
Standard Process said it has not received any adverse event reports (AERs) of illness related to these products.
The recalled products are:
Cataplex ACP (Product number 0700 and 0750) Lot 114marketed for cardiovascular health and immune function.
Cataplex C (Product number 1650 1655) Lot 114marketed for the immune system, skin and connective tissue, and bone health.
Pancreatrophin PMG (Product number 6650) Lot 114marketed for healthy pancreatic function.
The products, all tablets, were distributed in 60 cc and 200 cc amber glass bottles with Best Used By dates (BUB) of May 13 indicated on both the bottles and the boxes. No other products or lot numbers were affected.
Consumers who have purchased any of these three products with specific lot codes of L114 are urged to return it to the place of purchase for a full refund.
Salmonella risk has been the reason for recalls in the past, including a whey protein, trail mix and pistachios.
You May Also Like